Patterns of medical diagnosis and treatment of migraine and probable migraine in a health plan

Cephalalgia

Volumn 26, Issue 1, 2006, Pages 43-49

  Bigal, M E ^a,b,c   Kolodner, K B ^d   Lafata, J E ^e   Leotta, C ^d   Lipton, R B ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c NEW ENGLAND CENTER FOR HEADACHE   (United States)

^d AdvancePCS   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Diagnosis; Epidemiology; Probable migraine; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; BUTALBITAL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROERGOTAMINE; ERGOT DERIVATIVE; ISOMETHEPTENE; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROCHLORPERAZINE; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ERROR; EMERGENCY WARD; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NON PROFIT ORGANIZATION; OUTPATIENT CARE; PATIENT CARE; PATIENT CARE PLANNING; PRESCRIPTION; PROBABILITY; PROPHYLAXIS; RANDOMIZATION; TELEPHONE; TREATMENT PLANNING; VALIDITY;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIEMETICS; BARBITURATES; FEMALE; HEALTH CARE SURVEYS; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MIDDLE AGED; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PHYSICIAN'S PRACTICE PATTERNS; VASOCONSTRICTOR AGENTS;

EID: 33644943390     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2005.00988.x     Document Type: Article

References (24)

1. Rains JC Penzien DB Lipchik GL Ramadan NM Diagnosis of migraine: empirical analysis of a large clinical sample of atypical migraine (IHS 1.7) patients and proposed revision of the IHS criteria Cephalalgia 2001 21 584 95
2. Russell MB Olesen J Migrainous disorder and its relation to migraine without aura and migraine with aura. A genetic epidemiological study Cephalalgia 1996 16 431 5
3. Lipton RB Cady R Dodick D Diamond M Demographics of migrainous headache sufferers in the United States: additional data from the American Migraine Study II Headache 2002 42 440 (Abstract).
4. Headache Classification Committee of the International Headache Society. The international classification of headache disorders Cephalalgia 2004 24 1 160
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain Cephalalgia 1988 8 Suppl. 7 1 96
6. Patel N Bigal ME Kolodner K Leotta C Lafatta J Lipton RB The prevalence of migraine and probable migraine in a health plan Neurology 2004 63 1432 8
7. Tepper S Dodick D Cady R Lucas S Hutchinson S Few C Kuhn T Oral sumatriptan for probable migraine without aura (2004 IHS 1.6.1): results of a randomized, double-blind, placebo-controlled study Headache 2004 44 477 8
8. Lipton RB Stewart WF Diamond S Diamond ML Reed M Prevalence and burden of migraine in the United States: data from the American Migraine Study II Headache 2001 41 646 57
9. Lipton RB Diamond S Reed M Diamond ML Stewart WF Migraine diagnosis and treatment: results from the American Migraine Study II Headache 2001 41 638 45
10. Terwindt GM Ferrari MD Tijhuis M Groenen SM Picavet HS Launer LJ The impact of migraine on quality of life in the general population: the GEM study Neurology 2000 55 624 9
11. Stewart WF Shechter A Lipton RB Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration Neurology 1994 44 Suppl. 4 24 39
12. Lipton RB Amatniek JC Ferrari MD Gross M Migraine. Identifying and removing barriers to care Neurology 1994 44 Suppl. 4 63 8
13. Stang PE Von Korff M The diagnosis of headache in primary care: factors in the agreement of clinical and standardized diagnoses Headache 1994 34 138 42
14. Richard A Massiou H Herrmann MA Frequency and profile of migraine patients seen by general practitioners Semin Hosp Paris 1999 75 440 6
15. Lipton RB Stewart WF Acute migraine therapy: do doctors understand what migraine patients want from therapy? Headache 1999 39 Suppl. 2 20 6
16. Lipton RB Scher AI Kolodner K Liberman J Steiner TJ Stewart WF Migraine in the United States: epidemiology and patterns of health care use Neurology 2002 58 885 94
17. Henry P Auray JP Gaudin AF Dartigues JF Duru G Lanteri-Minet M et al Prevalence and clinical characteristics of migraine in France Neurology 2002 59 232 27
18. Stewart WF Lipton RB Whyte J Dowson A Kolodner K Liberman JN Sawyer J A international study to assess reliability of the Migraine Disability Assessment (MIDAS) Score Neurology 1999 53 988 94
19. Scher AI Stewart WF Lipton RB Migraine and headache: a meta-analytic approach. In: Crombie IK, editor Epidemiology of pain Seattle IASP Press 1999 159 70
20. Stewart WF Lipton RB Liberman J Variation in migraine prevalence by race Neurology 1996 47 52 9
21. Prichard BN Graham BR Cruickshank JM New approaches to the uses of beta blocking drugs in hypertension J Hum Hypertens 2000 14 Suppl. 1 S63
22. Ackermann RT Williams JW Jr. Rational treatment choices for non-major depressions in primary care: an evidence-based review J Gen Intern Med 2002 17 293 301
23. Clouse JC Osterhaus JT Healthcare resource use and costs associated with migraine in a managed healthcare setting Ann Pharmacother 1994 28 659 64
24. Goldfarb SD Duncan BS Dans PE Sloan AS HMO direct costs and health care resources use after implementation of a monthly limit on sumatriptan Am J Health Syst Pharm 1999 56 2206 10